Attendee search 

The project focuses on the research and development of anti-tumor photosensitizing drugs for photodynamic therapy, creating a research and development technology platform for photosensitizing drugs, and conducting clinical development and transformation of anti-tumor photosensitizing drugs. The new anti-tumor photosensitizer drugs developed by our team exhibited excellent tumor enrichment and high efficacy of photodynamic therapy. They have great potential for clinical development and application.

As the first professional injection producer in China,Shanghai Haipu Pharmaceutical factory was founded in 1925 and renamed as Shanghai Xudong Haipu Pharmaceutical Co.,Ltd after jointed with Taiwan Tungyang International Co.,Ltd in 1993.The company has developed for more than 90 years so far, and has accumulated rich experience in production and brand awareness.

世界500强医药企业，关注疫苗，糖尿病和创新药物

Mainly for investment services and project indUnited Statestrialization

广东省钟南山医学基金会是在名誉理事长钟南山院士支持下，由呼吸疾病国家重点实验室产学研基地、国家呼吸系统疾病临床医学研究中心产学研分中心、广州医科大学国家大学科技园发起，于2011年7月5日经广东省民政厅批复成立的非公募基金会。

证券公司研究所

康为同创集团成立于2006年，位于北京市密云区经济开发区内，主要从事特种传动设备、电机电气、高端智能装备、智能传感器、智能芯片等的研发、生产、制造，是集产、学、研于一体的大型智能生产制造企业。产品广泛应用于轨道交通、商用航空器、基础工业、智能城市等诸多领域。

企业从成立之日起始终秉承“用户第一、质量第一、信誉第一、智能第一、双赢第一”的原则。已成功申请为国家高新技术企业，并取得国际铁路行业IRIS认证证书。集团公司经多年发展已初步建立起以智能设计为先导的智能化生产制造企业。为适应智能事业的需要，集团公司不断为客户提高更优质的服务。

混合所有制企业。

We are the flagship subsidiary of China Resources Group, engaging in the research and development, manufacturing, distribution and retail of a broad range of pharmaceutical and healthcare products.In 2018, our total revenue is HK$ 189.7 billion.
Currently CR Pharma Group is one of the TOP 3 pharmacetucial group in China, and our core competences is capabilities are marketing&sales(3000+ Sales Reps for RX and 3000+ Sales Reps for OTC and healthcare products, local Regulatory Affairs(Dedicated RA team), and great manufacturing facilities(40+ manufacturing sites in China, including API and finished products of all dosage forms, 4 sites are approved by US FDA and EMEA).
As a listed company in HK, CR Pharma has estalished consodiated business reputation in healtcare industry and capital market. And currently, nearly all top 50 MNC pharmacetical companies are our business partner in China, and business scope includes JV, Licensing, Commercial Distribution.

Luye Pharma Group, a member of Luye Life Sciences Group, is an international pharmaceutical company with a focus on targeting central nervous system (CNS), oncology and other therapeutic areas. Global R&D, global manufacturing, and the global sale of innovative medications are the company’s three main strategic priorities.